РАЗВИТИЕ МЕТОДОВ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ ЛУЧЕВЫХ ЦИСТИТОВ

Библиографические ссылки:

Rapariz-Gonz´alez M., Castro-D´ıaz D., Mej´ıa-Rend´on D. Evaluation of the impact of the urinary symptoms on quality of life of patients with painful bladder syndrome/chronic pelvic pain and radiation cystitis: EURCIS study. Actas Urologicas Espanolas. 2014; 38(4): 224-231.https://doi.org/10.1016/j.acuroe.2014.02.008

Crew J.P., Jephcott C.R., Reynard J.M. Radiation-Induced Haemorrhagic Cystitis. Eur. Urol. 2001; 40: 111-123.https://doi.org/10.1159/000049760

Sismondi P., Sinistrero G., Zola P. et al. Complications of uterine cervix carcinoma Treatments: the problem of uniform classification. Radiother. Oncol. 1989; 14: 9-17.https://doi.org/10.1016/0167-8140(89)90003-0

Gelblum D.Y., Potters L. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2000; 48: 119-124.https://doi.org/10.1016/S0360-3016(00)00632-5

Неймарк А.И., Неймарк Б.А., Кондратьева Ю.С. Дизурический синдром у женщин: диагностика и лечение. Москва: ГЭОТАР-Медиа, 2010: 246 с.

Eugenio Bologna, Leslie Claire Licari, Antonio Franco, Costantino Leonardo Giuseppe Simone, Riccardo Autorino. Incidence and Management of Radiation Cystitis After Pelvic Radiotherapy for Prostate Cancer: Analysis From a National Database. Urology. 2024 Sep: 191: 86-92.https://doi.org/10.1016/j.urology.2024.04.035

Oravisto K.J. Epidemiology of interstitial cystitis. Ann Chirur Gynaecol Fenn. 1975; 64(2): 75-7. PMID: 1137336

Temml C., Wehrberger C., Riedl C., Ponholzer A., Marszalek M., Madersbacher S. Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project. Eur Urol. 2007: 51: 803-808.https://doi.org/10.1016/j.eururo.2006.08.028

Лоран О.Б., Синякова Л.А., Митрохин А.А., Плесковский А.М., Штейнберг М.Л., Винарова Н.А. Современный взгляд на проблему интерстициального цистита. Медицинский совет. 2011; 11-12: 15-19. – EDN PUISQH.

Кульчавеня Е.В., Неймарк А.И., Цуканов А.Ю., Неймарк А.Б., Раздорская М.В. Хронический цистит: как продлить безрецидивный период? Урология. 2023; 3: 34-41.https://doi.org/10.18565/urology.2023.3.34-41.. – EDN LDFZJM.

Clemens J.Q., Meenan R.T., Rosetti M.C., Gao S.Y., Calhoun E.A. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005; 173 (1): 98-102.https://doi.org/10.1097/01.ju.0000146114.53828.82

Миркин Я.Б., Карапетян А.В., Шумов С.Ю. Интерстициальный цистит: дискуссия о патогенезе, диагностике и лечении. Часть 1 – патогенез. Экспериментальная и клиническая урология. 2017; 4: 96-101. – EDN YNJPJN.

Berry S.H., Bogart L.M., Pham C., Liu K., Nyberg L., Stoto M., Suttorp M., Clemens J.Q. Development, validation and testing of an epidemiological case definition of interstitial cystitis/painful bladder syndrome. J. Urol. 2010; 183: 1848-1852.https://doi.org/10.1016/j.juro.2009.12.103

Konkle K.S., Berry S.H., Elliott M.N., Hilton L., Suttorp M.J., Clauw D.J., Clemens J.Q. Comparison of an interstitial cystitis/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study. J. Urol. 2012; 187: 508-512.https://doi.org/10.1016/j.juro.2011.10.040

Lee M.H., Chang K.M., Tsai W.C. Morbidity rate and medical utilization in interstitial cystitis/painful bladder syndrome. Int. Urogynecol. J. 2018; 29: 1045-1050.https://doi.org/10.1007/s00192-018-3574-x

Leppilahti M., Sairanen J., Tammela T.L., Aaltomaa S., Lehtoranta K., Auvinen A. Prevalence of clinically confirmed interstitial cystitis in women: A population based study in Finland. J. Urol. 2005; 174: 581-583.https://doi.org/10.1097/01.ju.0000165452.39125.98

Clemens J.Q., Link C.L., Eggers P.W., Kusek J.W., Nyberg L.M. et al. Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. J. Urol. 2007; 177: 1390-1394.https://doi.org/10.1016/j.juro.2006.11.084

Ito T., Miki M., Yamada T. Interstitial cystitis in Japan. BJU Int. 2000; 86: 634-637.https://doi.org/10.1046/j.1464-410X.2000.00855.x

Song Y., Zhang W., Xu B., Hao L., Song J. Prevalence and correlates of painful bladder syndrome symptoms in Fuzhou Chinese women. Neurourol. Urodyn. 2009; 28: 22-25.https://doi.org/10.1002/nau.20513

Apodaca G. The uroepithelium: not just a passive barrier. Traffic. 2004; 5(3): 117-28.https://doi.org/10.1046/j.1600-0854.2003.00156.x

Cox A., Golda N., Nadeau G., Nickel J.C., Carr L., Corcos J., Teichman J. CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can. Urol. Assoc. J. 2016; 10: E136-E155.https://doi.org/10.5489/cuaj.3786

Rabin C., O’Leary A., Neighbors C., Whitmore K. Pain and depression experienced by women with interstitial cystitis. Women Health. 2000; 31: 67-81.https://doi.org/10.1300/J013v31n04_05

Kanter G., Komesu Y.M., Qaedan F., Jeppson P.C., Dunivan G.C., Cichowski S.B., Rogers R.G. Mindfulness-based stress reduction as a novel treatment for interstitial cystitis/bladder pain syndrome: A randomized controlled trial. Int. Urogynecol. J. 2016; 27: 1705-1711.https://doi.org/10.1007/s00192-016-3022-8

Homma Y., Akiyama Y., Tomoe H., Furuta A., Ueda T., Maeda D., Lin A.T., Kuo H.C., Lee M.H., Oh S.J. et al. Clinical guidelines for interstitial cystitis/bladder pain syndrome. Int. J. Urol. 2020; 27: 578-589.https://doi.org/10.1111/iju.14234

Tripp D.A. Managing psychosocial correlates of urologic chronic pelvic pain syndromes: Advice from a urology pain psychologist. Can. Urol. Assoc. J. 2018; 12: S175-S177.https://doi.org/10.5489/cuaj.5329

Koziol J.A., Clark D.C., Gittes R.F., Tan E.M. The natural history of interstitial cystitis: a survey of 374 patients. J Urol. 1993: 149:465-469.https://doi.org/10.1016/S0022-5347(17)36120-7

Whitmore K.E. Self-care regimens for patients with interstitial cystitis. Urol Clin North Am. 1994: 21: 121-130. PMID: 8284835.https://doi.org/10.1016/S0094-0143(21)00601-7

Shorter B., Lesser M., Moldwin R.M., Kushner L. Effect of comestibles on symptoms of interstitial cystitis. J Urol. 2007; 178: 145-152.https://doi.org/10.1016/j.juro.2007.03.020

Webster D.C., Brennan T. Self-care strategies used for acute attack of interstitial cystitis. Urol Nurs. 1995; 15: 86-93. PMID: 7481892

Erickson D.R., Davies M.F. Interstitial cystitis. Int Urogynecol J. 1998; 9; 174-183.https://doi.org/10.1007/BF02001088

Oyama I.A., Rejba A., Lukban J.C., Fletcher E., Kellogg-Spadt S., Holzberg A.S., Whitmore K.E. Modified thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urology. 2004; 64: 862-865.https://doi.org/10.1016/j.urology.2004.06.065

Cummings T.M., White A.R. Needling therapies in the management of myofascial trigger point pain: A systematic review. Arch. Phys. Med. Rehab. 2001; 82: 986-992.https://doi.org/10.1053/apmr.2001.24023

Fitz Gerald M.P., Payne C.K., Lukacz E.S., Yang C.C., Peters K.M., Chai T.C., Nickel J.C., Hanno P.M., Kreder K.J., Burks D.A. et al. Randomized Multicenter Clinical Trial of Myofascial Physical Therapy in Women With Interstitial Cystitis/Painful Bladder Syndrome and Pelvic Floor Tenderness. J. Urol. 2012; 187: 2113-2118.https://doi.org/10.1016/j.juro.2012.01.123

Anderson R.U., Wise D., Sawyer T., Chan C. Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J. Urol. 2005; 174: 155-160.https://doi.org/10.1097/01.ju.0000161609.31185.d5

Hanno P.M., Erickson D., Moldwin R., Faraday M.M. Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline Amendment. J. Urol. 2015; 193: 1545-1553.https://doi.org/10.1016/j.juro.2015.01.086

Clemens J.Q., Erickson D.R., Varela N.P., Lai H.H. Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome. J. Urol. 2022; 208: 34-42.https://doi.org/10.1097/JU.0000000000002756

Hanno P.M., Burks D.A., Clemens J.Q., Dmochowski R.R., Erickson D., FitzGerald M.P., Forrest J.B., Gordon B., Gray M., Mayer R.D. et al. AUA Guideline for the Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome. J. Urol. 2011; 185: 2162-2170.https://doi.org/10.1016/j.juro.2011.03.064

Chaiken D.C., Blaivas J.G., Blaivas S.T. Behavioral therapy for the treatment of refractory interstitial cystitis. J. Urol. 1993; 149: 1445-1448.https://doi.org/10.1016/S0022-5347(17)36411-X

Лоран О.Б., Синякова Л.А., Косова И.В. Медикаментозное лечение интерстициального цистита. Медицинский совет. 2008; 1-2; 20-26. – EDN MLIRVZ.

Ophoven A. van, Pokupic S., Heineke A., Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004; 172: 533-536.https://doi.org/10.1097/01.ju.0000132388.54703.4d

Giannantoni A., Bini V., Dmochowski R., Hanno P., Nickel J.C., Proietti S. et al. Contemporary management of the painful bladder: a systematic review. Eur Urol. 2012; 61: 29-53.https://doi.org/10.1016/j.eururo.2011.07.069

Hertle L., Ophoven A. van. Long-term results of amitriptyline treatment for interstitial cystitis. Aktuelle Urol. 2010; 41 (Suppl. 1): S61-S65.https://doi.org/10.1055/s-0029-1224651

Parsons C.L., Mulholland S.G. Successful therapy of interstitial cystitis with pentosanpolysulfate. J Urol. 1987; 138: 513-516.https://doi.org/10.1016/S0022-5347(17)43243-5

Mulholland S.G., Hanno P., Parsons C.L., Sant G.R., Staskin D.R. Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. Urology. 1990; 35: 552-558.https://doi.org/10.1016/0090-4295(90)80116-5

Holm-Bentzen M., Jacobsen F., Nerstrøm B., Lose G., Kristensen J.K., Pedersen R.H. et al. A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J Urol. 1987; 138: 503-507.https://doi.org/10.1016/S0022-5347(17)43241-1

Parsons C.L. Current strategies for managing interstitial cystitis. Expert Opin Pharmacother. 2004; 5: 287-293.https://doi.org/10.1517/14656566.5.2.287

Parsons C.L., Schmidt J.D., Pollen J.J. Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. J Urol. 1983; 130: 51-53.https://doi.org/10.1016/S0022-5347(17)50948-9

Fritjofsson A., Fall M., Juhlin R., Persson B.E., Ruutu M. Treatment of ulcer and nonulcer interstitial cystitis with sodium pentosanpolysulfate: a multicenter trial. J Urol. 1987; 138: 508-512.https://doi.org/10.1016/S0022-5347(17)43242-3

Parsons C.L., Benson G., Childs S.J., Hanno P., Sant G.R., Webster G. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol. 1993; 150: 845-848.https://doi.org/10.1016/S0022-5347(17)35629-X

Philip M. Hanno. Analysis of long-term Elmiron therapy for interstitial cystitis. J Urology. 1997.https://doi.org/10.1016/S0090-4295(97)00179-9

Matsuda S., Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology. 2000; 47: 119-125.https://doi.org/10.1016/S0162-3109(00)00192-2

Krishnaswamy G., Kelley J., Johnson D., Youngberg G., Stone W., Huang S.K., et al. The human mast cell: functions in physiology and disease. Front Biosci. 2001; 6: 1109-1127.https://doi.org/10.2741/krishnas

Sairanen J., Forsell T., Ruutu M. Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol. 2004; 171: 2138-2141.https://doi.org/10.1097/01.ju.0000125139.91203.7a

Sairanen J., Tammela T.L., Leppilahti M., Multanen M., Paananen I., Lehtoranta K. et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol. 2005; 174: 2235-2238.https://doi.org/10.1097/01.ju.0000181808.45786.84

Warren J.W., Horne L.M., Jebel J.R., Marvel R.P., Keay S.K., Chai T.C. Pilot study of sequential oral antibiotics for the treatment of interstitial cystitis. J Urol. 2000 Jun; 163(6): 1685-8. PMID: 10799160

Арбух Д.М., Абузарова Г.Р., Алексеева Г.С. Опиоидные анальгетики в терапии болевых синдромов (часть 1). Вестник анестезиологии и реаниматологии. 2017; 14(3): 58-67.https://doi.org/10.21292/2078-5658-2017-14-3-58-67

Jiang Y.H., Peng C.H., Liu H.T., Kuo H.C. Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome. PLoS ONE. 2013; 8: e76779.https://doi.org/10.1371/journal.pone.0076779

Bosch P.C. A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome. J. Urol. 2014; 191: 77-82.https://doi.org/10.1016/j.juro.2013.06.038

Di X.P., Luo D.Y., Jin X., Zhao W.Y., Li H., Wang K.J. Efficacy and safety comparison of pharmacotherapies for interstitial cystitis and bladder pain syndrome: A systematic review and Bayesian network meta-analysis. Int. Urogynecol. J. 2021; 32: 1129-1141.https://doi.org/10.1007/s00192-020-04659-w

Nickel J.C., Mills I.W., Crook T.J., Jorga A., Smith M.D., Atkinson G., Krieger J.N. Tanezumab Reduces Pain in Women with Interstitial Cystitis/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic Syndromes. J. Urol. 2016; 195: 942-948.https://doi.org/10.1016/j.juro.2015.10.178

Wang H., Russell L.J., Kelly K.M., Wang S. Thipphawong J. Fulranumab in patients with interstitial cystitis/bladder pain syndrome: Observations from a randomized, double-blind, placebo-controlled study. BMC Urol. 2017; 17: 2.https://doi.org/10.1186/s12894-016-0193-z

Lee J., Doggweiler-Wiygul R., Kim S., Hill B.D., Yoo T.J. Is interstitial cystitis an allergic disorder?: A case of interstitial cystitis treated successfully with anti-IgE. Int. J. Urol. 2006; 13: 631-634.https://doi.org/10.1111/j.1442-2042.2006.01373.x

Dawson T.E., Jamison J. Intravesical treatments for painful bladder syndrome/interstitial cystitis. Cochrane Database Syst Rev. 2007; 4: CD006113.https://doi.org/10.1002/14651858.cd006113.pub2

Perez-Marrero R., Emerson L.E., Feltis J.T. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol. 1988; 140: 36-39.https://doi.org/10.1016/S0022-5347(17)41478-9

Rossberger J., Fall M., Peeker R. Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome. Scand J Nephrol. 2005; 39: 73-77.https://doi.org/10.1080/00365590410018738

Parsons C.L., Housley T., Schmidt J.D., Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br J Urol. 1994; 73: 504-507.https://doi.org/10.1111/j.1464-410x.1994.tb07634.x

Kallestrup E.B., Jorgensen S.S., Nordling J., Hald T. Treatment of interstitial cystitis with Cystistat: a hyaluronic acid product. Scand J Urol Nephrol. 2005; 39: 143-147.https://doi.org/10.1080/00365590410015876-1

Iavazzo C., Athanasiou S., Pitsouni E., Falagas M.E. Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis? Eur Urol. 2007; 51: 1534-1540.https://doi.org/10.1016/j.eururo.2007.03.020

Riedl C.R., Engelhardt P.F., Daha K.L., Morakis N., Pfluger H. Hyaluronan treatment of interstitial cystitis/painful bladder syndrome. Int Urogynecol J. 2008; 19: 717-721.https://doi.org/10.1007/s00192-007-0515-5

Agt S. Van, Gobet F., Sibert L., Leroi A.M., Grise P. Treatment of interstitial cystitis by intravesical instillation of hyaluronic acid: a prospective study on 31 patients. Prog Urol. 2011; 21: 218-225.https://doi.org/10.1016/j.purol.2010.07.016

Andrew Chen, Robert H. Shahiyan, Jennifer T. Anger. Interstitial Cystitis/Bladder Pain Syndrome Treatment: A Systematic Review of Sexual Health Outcomes. Sexual Medicine Reviews. 2022; 10(1): 71-76.https://doi.org/10.1016/j.sxmr.2020.12.005

Asklin B., Cassuto J. Intravesical lidocaine in severe interstitial cystitis: case report. Scand J Urol Nephrol. 1989; 23: 311-312.https://doi.org/10.3109/00365598909180345

Rosamilia A., Dwyer P.L., Gibson J. Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis. Int Urogynecol J. 1997; 8: 142-145.https://doi.org/10.1007/BF02764846

Sant G.R., LaRock D.R. Standard intravesical therapies for interstitial cystitis. Urol Clin North Am. 1994; 21: 73-83. PMID: 8284849.https://doi.org/10.1016/S0094-0143(21)00594-2

Davis E.L., Khoudary El S.R., Talbott E.O., Davis J., Regan L.J. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol. 2008; 179: 177-185.https://doi.org/10.1016/j.juro.2007.08.170

Barbalias G.A., Liatsikos E.N., Athanasopoulos A., Nikiforidis G. Interstitial cystitis: bladder training with intravesical oxybutynin. J Urol, 2000; 163: 1818-1822.https://doi.org/10.1016/S0022-5347(05)67551-9

Madersbacher H., van Ophoven A., van Kerrebroeck P.E. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans – a review. Neurourol Urodyn. 2013 Jan; 32(1) 9-18.https://doi.org/10.1002/nau.22256

Pinto R., Lopes T., Frias B., Silva A., Silva J.A., Silva C.M. et al. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol. 2010; 58: 360-365.https://doi.org/10.1016/j.eururo.2010.02.031

Smith C.P., Radziszewski P., Borkowski A., Somogyi G.T., Boone T.B., Chancellor M.B. Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology. 2004; 64: 871-875.https://doi.org/10.1016/j.urology.2004.06.073

Giannantoni A., Costantini E., Di Stasi S.M., Tascini M.C., Bini V., Porena M. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study. Eur Urol. 2006; 49: 704-709.https://doi.org/10.1016/j.eururo.2005.12.002

Liu H.T., Kuo H.C. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology. 2007; 70: 463-468.https://doi.org/10.1016/j.urology.2007.04.038

Giannantoni A., Porena M., Costantini E., Zucchi A., Mearini L., Mearini E. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year follow up. J Urol. 2008; 179: 1031-1034.https://doi.org/10.1016/j.juro.2007.10.032

de Miquel F., Chancellor M.B. Pittsburgh experience with botulinum toxin A injection. Actas Urol Esp, 2006; 30: 310-314.https://doi.org/10.1016/S0210-4806(06)73445-3

Tirumuru S., Al-Kurdi D., Latthe P. Intravesical botulinum toxin A injections in the treatment of painful bladder syndrome/interstitial cystitis: a systematic review. Int Urogynecol J. 2010; 21: 1285-1300.https://doi.org/10.1007/s00192-010-1162-9

Jing Zhang, Jiarui Kang, Liyang Wu. The potential mechanism of treating IC/BPS with hyperbaric oxygen by reducing vascular endothelial growth inhibitor and hypoxia-inducible factor-1α. Turk J Med Sci. 2023 Dec 11; 54(1): 26-32.https://doi.org/10.55730/1300-0144.5762

Лоран О.Б., Синякова Л.А., Серегин А.В., Митрохин А.А., Плесовский А.М., Винарова Н.А. Гипербарическая оксигенация при лечении пациентов с интерстициальным циститом: клиническое и морфологическое обоснование. Урология. 2011; 3: 3-5. – EDN NWFAEF.

Bumpus H.J. Interstitial cystitis: its treatment by over-distention of the bladder. Med Clin North Am. 1930; 13: 1495-1498.

Hanno P.M., Wein A.J. Conservative therapy of interstitial cystitis. Semin Urol. 1991; 9: 143-147.https://doi.org/10.1007/978-1-4471-3293-6_17

Yamada T., Murayama T., Andoh M. Adjuvant hydrodistension under epidural anesthesia for interstitial cystitis. Int J Urol. 2003; 10: 463-468.https://doi.org/10.1046/j.1442-2042.2003.00664.x

Tomoe H., Kobayashi H., Nakazawa H., Toma H. The efficacy of hydrodistention of the bladder for interstitial cystitis. J Interst Cyst. 2004; 2: 24-31.

Ottem D.P., Teichman J.M.H. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology. 2005; 66: 494-499.https://doi.org/10.1016/j.urology.2005.04.011

McCahy P.J., Styles R.A. Prolonged bladder distention: experience in the treatment of detrusor overactivity and interstitial cystitis. Eur Urol. 1995; 28: 325-327.https://doi.org/10.1159/000475075

Glemain P., Riviere C., Lenormand L., Karam G., Bouchot O., Buzelin J.M. Prolonged hydrodistention of the bladder for symptomatic treatment of interstitial cystitis: efficacy at 6 months and 1 year. Eur Urol. 2002; 41: 79-84.https://doi.org/10.1016/s0302-2838(01)00006-9

Hsieh C.H., Chang S.T., Hsieh C.J., Hsu C.S., Kuo T.C., Chang H.C. et al. Treatment of interstitial cystitis with hydrodistention and bladder training. Int Urogynecol J. 2008; 19: 1379-1384.https://doi.org/10.1007/s00192-008-0640-9